Weekly exenatide listed for type 2 diabetes

A once-weekly subcutaneous injection of exenatide is being funded on the PBS as part of a $70 million round of new listings.

The glucagon-like peptide-1 (GLP-1) analogue has been available on the PBS as a twice-daily subcutaneous injection (Byetta) since 2010.